Celexa Scripts For Patients Under 20 Account For 4% Of Use - Forest
Executive Summary
Forest/Warner-Lambert's antidepressant Celexa (citalopram) is seeing some off-label use in the pediatric/adolescent patient population; about 4% of Celexa use has been in patients under 20 years old.
You may also be interested in...
Warner-Lambert Sales Productivity Would Be Focus Of Pfizer Integration
One focus of Pfizer's integration of Warner-Lambert would be on raising the productivity of the Parke-Davis sales organization to Pfizer's "best-in-class" level, Pfizer told a Nov. 16 meeting with securities analysts.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials